Cargando…

Efficacy and Safety of Infliximab in Intestinal Behçet’s Disease: A Multicenter, Phase 3 Study (BEGIN)

BACKGROUND/AIMS: To date, there is no prospective study that specifically investigated the efficacy of infliximab in intestinal Behçet’s disease (BD). This study evaluated the efficacy of infliximab in patients with moderate-to-severe active intestinal BD that are refractory to conventional therapie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheon, Jae Hee, Kim, Hyun-Soo, Han, Dong Soo, Kim, Sung Kook, Shin, Sung Jae, Kim, Joo Sung, Ye, Byong Duk, Song, Geun Am, Lee, YoungJa, Kim, Youngdoe, Lee, Yoosun, Kim, Won Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10502498/ https://www.ncbi.nlm.nih.gov/pubmed/36578194 http://dx.doi.org/10.5009/gnl220278

Ejemplares similares

Early Infliximab Trough Levels Predict the Long-term Efficacy of Infliximab in a Randomized Controlled Trial in Patients with Active Crohn’s Disease Comparing, between CT-P13 and Originator Infliximab
por: Park, Jihye, et al.
Publicado: (2023)

Efficacy and Safety of Infliximab Therapy and Predictors of Response in Korean Patients with Crohn's Disease: A Nationwide, Multicenter Study
por: Choi, Chang Hwan, et al.
Publicado: (2016)

Real-World Safety and Effectiveness of Golimumab in Rheumatic Diseases: Post-Marketing Surveillance in Korea
por: Kim, Hyeongyeong, et al.
Publicado: (2021)

Crohn's Disease Clinical Network and Cohort (CONNECT) Study: The First Step Toward Nationwide Multicenter Research of Crohn's Disease in Korea
por: Cheon, Jae Hee, et al.
Publicado: (2014)

Overlooked Management and Risk Factors for Anemia in Patients with Intestinal Behçet’s Disease in Actual Clinical Practice
por: Kim, Bun, et al.
Publicado: (2015)

Infliximab versus Cyclosporine Treatment for Severe Corticosteroid-Refractory Ulcerative Colitis: A Korean, Retrospective, Single Center Study
por: Kim, Eun Hye, et al.
Publicado: (2015)

Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?
por: Kim, Duk Hwan, et al.
Publicado: (2016)

Radiation Exposure from Abdominal Imaging Studies in Patients with Intestinal Behçet Disease
por: Jung, Yoon Suk, et al.
Publicado: (2014)

Effectiveness and Safety of Golimumab in Patients with Ulcerative Colitis: A Multicenter, Prospective, Postmarketing Surveillance Study
por: Yu, Jongwook, et al.
Publicado: (2022)

Effect of Probiotic Lactobacillus (Lacidofil® Cap) for the Prevention of Antibiotic-associated Diarrhea: A Prospective, Randomized, Double-blind, Multicenter Study
por: Song, Hyun Joo, et al.
Publicado: (2010)

Outcome Predictors for Intestinal Behçet's Disease
por: Park, Jae Jun, et al.
Publicado: (2013)

Correlation between Soluble Triggering Receptor Expressed on Myeloid Cells-1 and Endoscopic Activity in Intestinal Behçet's Disease
por: Lee, Hyun Jung, et al.
Publicado: (2014)

Clinical Features of Intra-Abdominal Abscess and Intestinal Free-Wall Perforation in Korean Patients with Crohn’s Disease: Results from the CONNECT Study
por: Jeong, Seok-Hoo, et al.
Publicado: (2020)

Long-Term Outcomes of Cytomegalovirus Reactivation in Patients with Moderate to Severe Ulcerative Colitis: A Multicenter Study
por: Kim, You Sun, et al.
Publicado: (2014)

Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn’s Disease: Results from the CONNECT Study
por: Kwon, Jee Hye, et al.
Publicado: (2016)

Real-world effectiveness and safety of adalimumab in Korean patients with intestinal Behcet’s disease: a Korean Association for the Study of Intestinal Diseases (KASID) multicenter study
por: Lee, Seung Bum, et al.
Publicado: (2023)

The Clinical Characteristics and Prognosis of Crohn’s Disease in Korean Patients Showing Proximal Small Bowel Involvement: Results from the CONNECT Study
por: Kim, One Zoong, et al.
Publicado: (2018)

C-reactive protein is associated with postoperative outcomes in patients with intestinal Behçet’s disease
por: Kang, Eun Ae, et al.
Publicado: (2021)

Efficacy and tolerability of methotrexate therapy for refractory intestinal Behçet's disease: a single center experience
por: Park, Jihye, et al.
Publicado: (2018)

Effect of Thiopurine on Potential Surgical Intervention in Crohn’s Disease in Korea: Results from the CONNECT Study
por: Kim, Hee Man, et al.
Publicado: (2020)

Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease
por: Oh, Eun Hye, et al.
Publicado: (2017)

Correlation between Fluorescein Angiographic Findings and Visual Acuity in Behçet Retinal Vasculitis
por: Kim, Min, et al.
Publicado: (2015)

Identification of genetic susceptibility loci for intestinal Behçet’s disease
por: Kim, Seung Won, et al.
Publicado: (2017)

Clinical Factors and Disease Course Related to Diagnostic Delay in Korean Crohn’s Disease Patients: Results from the CONNECT Study
por: Moon, Chang Mo, et al.
Publicado: (2015)

Proteomics-based functional studies reveal that galectin-3 plays a protective role in the pathogenesis of intestinal Behçet’s disease
por: Lee, Hyun Jung, et al.
Publicado: (2019)

Gastric lesions in patients with Crohn's disease in Korea: a multicenter study
por: So, Hoonsub, et al.
Publicado: (2016)

Postoperative course of Crohn disease according to timing of bowel resection: Results from the CONNECT Study
por: Lee, Ji Min, et al.
Publicado: (2018)

Comparison of Long-term Outcomes of Infliximab versus Adalimumab Treatment in Biologic-Naïve Patients with Ulcerative Colitis
por: Lee, Yong Il, et al.
Publicado: (2021)

Development of a Novel Endoscopic Scoring System to Predict Relapse after Surgery in Intestinal Behçet’s Disease
por: Park, Jung Won, et al.
Publicado: (2018)

Clinical Characteristics of Korean Patients with Elderly-Onset Crohn’s Disease: Results from the Prospective CONNECT Study
por: Kim, You Sun, et al.
Publicado: (2022)

Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor α monoclonal antibody (Infliximab)
por: Lee, Jung Hoon, et al.
Publicado: (2007)

Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn’s Disease in Korea: Results from the CONNECT Study
por: Chun, Jaeyoung, et al.
Publicado: (2018)

Unmet Psychosocial Needs of Patients with Newly Diagnosed Ulcerative Colitis: Results from the Nationwide Prospective Cohort Study in Korea
por: Moon, Jung Rock, et al.
Publicado: (2020)

Corrigendum: Unmet Psychosocial Needs of Patients Newly Diagnosed with Ulcerative Colitis: Results from the Nationwide Prospective Cohort Study in Korea
por: Moon, Jung Rock, et al.
Publicado: (2021)

Beginning the Journey to Find Optimal Antithrombotic Regimens for Korean Patients with Atrial Fibrillation after Percutaneous Coronary Intervention
por: Kim, Sung Soo, et al.
Publicado: (2021)

Risk Factors for Surgery in Patients with Intestinal Behçet’s Disease During Anti-Tumor Necrosis Factor-Alpha Therapy
por: Han, So Jung, et al.
Publicado: (2023)

Incidence and risk factors of micronutrient deficiency in patients with IBD and intestinal Behçet’s disease: folate, vitamin B12, 25-OH-vitamin D, and ferritin
por: Park, Yong Eun, et al.
Publicado: (2021)

A Case of Behçet’s Disease with Superior and Inferior Vena Caval Occlusion
por: Yoo, Wan-Hee, et al.
Publicado: (1998)

Anti-Cyclic Citrullinated Peptide Antibodies and Joint Involvement in Behçet's Disease
por: Cho, Sung Bin, et al.
Publicado: (2012)

A Randomized, Phase I Pharmacokinetic Study Comparing SB2 and Infliximab Reference Product (Remicade(®)) in Healthy Subjects
por: Shin, Donghoon, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nm96s67ugkjuvdkhacp4jdsrk6